Empirical Second-Line Therapy in 5,000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg)
出版年份 2021 全文链接
标题
Empirical Second-Line Therapy in 5,000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg)
作者
关键词
-
出版物
Clinical Gastroenterology and Hepatology
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2021-12-23
DOI
10.1016/j.cgh.2021.12.025
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Room for Improvement in the Treatment of Helicobacter pylori Infection
- (2021) Olga P. Nyssen et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Impact of antimicrobial resistance rates on eradication of Helicobacter pylori in a United States population
- (2021) Erick A. Argueta et al. GASTROENTEROLOGY
- Adverse Event Profile During the Treatment of Helicobacter pylori
- (2021) Olga P. Nyssen et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- AGA Clinical Practice Update on the Management of Refractory Helicobacter pylori Infection: Expert Review
- (2021) Shailja C. Shah et al. GASTROENTEROLOGY
- Helicobacter pylori resistance to antibiotics in Europe in 2018 and its relationship to antibiotic consumption in the community
- (2021) Francis Megraud et al. GUT
- European Registry on Helicobacter pylori management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients
- (2020) Olga P Nyssen et al. GUT
- European Registry on Helicobacter pylori Management: Effectiveness of First and Second-Line Treatment in Spain
- (2020) María Caldas et al. Antibiotics-Basel
- European Registry on Helicobacter pylori management: Single‐capsule bismuth quadruple therapy is effective in real‐world clinical practice
- (2020) Olga P. Nyssen et al. United European Gastroenterology Journal
- Meta‐analysis of three‐in‐one single capsule bismuth‐containing quadruple therapy for the eradication of Helicobacter pylori
- (2019) Olga P. Nyssen et al. HELICOBACTER
- Combination of Bismuth and Standard Triple Therapy Eradicates Helicobacter pylori Infection in More than 90% of Patients
- (2019) Adrian G. McNicholl et al. Clinical Gastroenterology and Hepatology
- Protocol of the European Registry on the management of Helicobacter pylori infection (Hp‐EuReg)
- (2019) Adrian G. McNicholl et al. HELICOBACTER
- Emergence of Global Antibiotic Resistance
- (2018) Martha Shawn Morehead et al. PRIMARY CARE
- Relative potency of proton-pump inhibitors, Helicobacter pylori therapy cure rates, and meaning of double-dose PPI
- (2018) David Y. Graham et al. HELICOBACTER
- Optimization strategies aimed to increase the efficacy of H. pylori eradication therapies
- (2017) Javier P. Gisbert et al. HELICOBACTER
- Comparison of Helicobacter pylori Eradication Rates of 2-Week Levofloxacin-Containing Triple Therapy, Levofloxacin-Containing Bismuth Quadruple Therapy, and Standard Bismuth Quadruple Therapy as a First-Line Regimen
- (2017) Evrim Kahramanoğlu Aksoy et al. MEDICAL PRINCIPLES AND PRACTICE
- Rescue Therapy for Helicobacter pylori Eradication: A Randomized Non-Inferiority Trial of Amoxicillin or Tetracycline in Bismuth Quadruple Therapy
- (2016) Qi Chen et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Levofloxacin, bismuth, amoxicillin and esomeprazole as second-line Helicobacter pylori therapy after failure of non-bismuth quadruple therapy
- (2016) Zhiqiang Song et al. DIGESTIVE AND LIVER DISEASE
- Management ofHelicobacter pyloriinfection—the Maastricht V/Florence Consensus Report
- (2016) P Malfertheiner et al. GUT
- Efficacy of 7-Day and 14-Day Triple Therapy Regimens for the Eradication ofHelicobacter pylori: A Comparative Study in a Cohort of Romanian Patients
- (2016) Stefan Sorin Arama et al. Gastroenterology Research and Practice
- Helicobacter pylorisecond-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments
- (2015) J. P. Gisbert et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Fourteen-day optimized levofloxacin-based therapy versus classical quadruple therapy for Helicobacter pylori treatment failures: a randomized clinical trial
- (2015) Zhijun Cao et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Efficacy of Bismuth-Containing Quadruple Therapies for Clarithromycin-, Metronidazole-, and Fluoroquinolone-Resistant Helicobacter pylori Infections in a Prospective Study
- (2013) Xiao Liang et al. Clinical Gastroenterology and Hepatology
- Rational Helicobacter pylori Therapy: Evidence-Based Medicine Rather Than Medicine-Based Evidence
- (2013) David Y. Graham et al. Clinical Gastroenterology and Hepatology
- The Efficacy of Second-Line Anti-Helicobacter pyloriTherapy Using an Extended 14-Day Levofloxacin/Amoxicillin/Proton-Pump Inhibitor Treatment - A Pilot Study
- (2012) Seng-Kee Chuah et al. HELICOBACTER
- The challenge of Helicobacter pylori resistance to antibiotics: the comeback of bismuth-based quadruple therapy
- (2012) Francis Mégraud Therapeutic Advances in Gastroenterology
- Bismuth improves PPI-based triple therapy for H. pylori eradication
- (2010) Peter Malfertheiner Nature Reviews Gastroenterology & Hepatology
- Therapy for Helicobacter pylori Infection Can be Improved
- (2008) David Y Graham et al. DRUGS
- Relative potency of proton-pump inhibitors—comparison of effects on intragastric pH
- (2008) Julia Kirchheiner et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support
- (2008) Paul A. Harris et al. JOURNAL OF BIOMEDICAL INFORMATICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More